Breath metabolomics to determine the sputum inflammatory markers of asthma and COPD
Using breath metabolomics in conjunction with sputum inflammatory phenotyping shows promise in effectively distinguishing between asthma and COPD, as well as identifying inflammatory subtypes, which can aid in creating personalized treatment strategies.
Authors
- Hamza Mostafa (ORCID: https://orcid.org/0000-0003-4319-9542)
- Mahmoud M. Dahab (ORCID: https://orcid.org/0000-0001-8570-4311)
- S Fowler
- Maria Basanta
- Ibrahim Baharudin
Institutions
- University of Malaya (MY)
- Manchester University NHS Foundation Trust (GB)
- Universitat Rovira i Virgili (ES)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1080/02770903.2025.2612527
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00